Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (981)
All Articles published online
|
Publishing Process of This Article
|
Aug 24, 2025 (publication date) through Dec 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Sun X, Shi XW, Han L, Zhang YF, Xu Y, Lu YC. Recent progress in the use of periplocin, periplocymarin and periplogenin in cancer treatment. World J Clin Oncol 2025; 16(8): 107490 [PMID: 40901321 DOI: 10.5306/wjco.v16.i8.107490] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Sun X, Shi XW, Han L, Zhang YF, Xu Y, Lu YC. Recent progress in the use of periplocin, periplocymarin and periplogenin in cancer treatment. World J Clin Oncol 2025; 16(8): 107490 [PMID: 40901321 DOI: 10.5306/wjco.v16.i8.107490] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i8/107490.htm |
| Number | Citing Articles |
| 1 |
Heerim Yeo, Sang-Yun Kim, Sang-Min Park. Harnessing transcriptomics for discovery of natural products to overcome acquired cancer resistance. Archives of Pharmacal Research 2025; doi: 10.1007/s12272-025-01590-w
|